Carlyle weighs bid for Dr. Martens
Permira finds the first bidder for Dr. Martins. Carlyle Group is considering a bid for the British bootmaker, according to Sky News. The investment firm is in the early stages of deliberations on a potential offer and no final decisions have been made.
Earlier this year, Permira hired Goldman Sachs Group and Robert W. Baird to explore options for Dr. Martens, including a sale or IPO. The investment firm targets an exit in 2020. Carlyle has owned Goolden Goose since 2017 and it has invested in Supreme and Spanish Jeanologia.
Dr. Martens was founded in the 1940s by German doctor Klaus Martens. In the year ended March 31, Dr. martens delivered a 30% revenue growth, to 454.4 million pounds, with double digit growth across all channels. Ebitda grew 70%, to 85 million pounds
info@themds.com
Validation policy for comments:
MDS does not perform prior verification for the publication of comments. However, to prevent anonymous comments from affecting the rights of third parties without the ability to reply, all comments require a valid email address, which won’t be visible or shared.
Enter your name and email address to be able to comment on this news: once you click on the link you will find within your verification email, your comment will be published.